Filing Details
- Accession Number:
- 0000899243-16-029177
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-09-16 19:23:53
- Reporting Period:
- 2016-09-14
- Filing Date:
- 2016-09-16
- Accepted Time:
- 2016-09-16 19:23:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1520697 | Acadia Healthcare Company Inc. | ACHC | () | DE |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1487016 | Waud Capital Partners Iii, L.p. | 300 N. Lasalle Street, Suite 4900 Chicago IL 60654 | No | No | Yes | No | |
| 1487019 | Waud Capital Partners Qp Iii, L.p. | 300 N. Lasalle Street, Suite 4900 Chicago IL 60654 | No | No | Yes | No | |
| 1532461 | Waud Capital Partners Iii, L.l.c. | 300 N. Lasalle Street, Suite 4900 Chicago IL 60654 | No | No | Yes | No | |
| 1532462 | Waud Capital Partners Management Iii, L.p. | 300 N. Lasalle Street, Suite 4900 Chicago IL 60654 | No | No | Yes | No | |
| 1532465 | Wcp Fif Iii (Acadia), L.p. | 300 N. Lasalle Street, Suite 4900 Chicago IL 60654 | No | No | Yes | No | |
| 1532468 | Waud Capital Affiliates Iii, L.l.c. | 300 N. Lasalle Street, Suite 4900 Chicago IL 60654 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.01 Per Share | Disposition | 2016-09-14 | 46,302 | $50.19 | 2,252,406 | No | 4 | S | Indirect | See footnotes |
| Common Stock, Par Value $0.01 Per Share | Disposition | 2016-09-15 | 123,473 | $49.24 | 2,128,933 | No | 4 | S | Indirect | See footnotes |
| Common Stock, Par Value $0.01 Per Share | Disposition | 2016-09-16 | 287,668 | $47.74 | 1,841,265 | No | 4 | S | Indirect | See footnotes |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | See footnotes |
| No | 4 | S | Indirect | See footnotes |
| No | 4 | S | Indirect | See footnotes |
Footnotes
- Represents shares sold in market transactions under Rule 144 as follows: (i) 1,154 shares by Waud Capital Partners III, L.P. ("WCP III"), (ii) 25,449 shares by Waud Capital Partners QP III, L.P. ("Waud QP III"), (iii) 14,397 shares by WCP FIF III (Acadia), L.P. ("WCP FIF III") and (iv) 5,302 shares by Waud Capital Affiliates III, L.L.C. ("Waud Affiliates III").
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $50.00 to $50.54, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote (1) to this Form 4.
- Reeve B. Waud is a member of the board of directors of Acadia Healthcare Company, Inc. Mr. Waud is also the manager of Waud Capital Partners III, L.L.C. ("Waud III LLC") and a member of the Limited Partner Committee of Waud Capital Partners Management III, L.P. ("WCPM III"). Waud III LLC is the general partner of WCPM III. WCPM III is the general partner of WCP III, Waud QP III and WCP FIF III and the manager of Waud Affiliates III. As a result, each of Mr. Waud, Waud III LLC and WCPM III may be deemed to share beneficial ownership of the reported shares.
- Represents shares sold in market transactions under Rule 144 as follows: (i) 3,077 shares by WCP III, (ii) 67,867 shares by Waud QP III, (iii) 38,394 shares by WCP FIF III and (iv) 14,135 shares by Waud Affiliates III.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $49.00 to $49.67, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote (4) to this Form 4.
- Represents shares sold as follows: (i) 7,170 shares by WCP III, (ii) 158,116 shares by Waud QP III, (iii) 89,451 shares by WCP FIF III and (iv) 32,931 shares by Waud Affiliates III.
- The reported shares are owned of record as follows: (i) 183,205 shares by WCP III, (ii) 1,036,001 shares by Waud QP III, (iii) 454,671 shares by WCP FIF III and (iv) 167,388 shares by Waud Affiliates III.
- Each of the reporting persons expressly disclaims beneficial ownership of the reported shares except to the extent of its pecuniary interest therein.
Billionaire Hedge Funds
